Navigation Links
NCPA Testifies Before California Board of Pharmacy on E-Pedigree
Date:12/5/2007

SACRAMENTO, Calif., Dec. 5 /PRNewswire-USNewswire/ -- Dave Wilcox, RPh, owner of Northwest Medical Pharmacy in Fresno, Calif., testified today on behalf of the National Community Pharmacists Association (NCPA) before the Enforcement Committee of the California Board of Pharmacy at the E-pedigree hearing. All members of the pharmaceutical community have to comply with a well-functioning interoperable system of E-pedigree and track and trace technology by January 1, 2009, in order to strengthen the chain of custody for drugs by preventing diversions and counterfeit products from entering the marketplace.

Wilcox's primary recommendation was delaying the implementation date to provide the necessary time to ensure proper compliance. He said, "To get right to the point, the January 1, 2009 deadline is impossible for independent pharmacy to achieve. This is largely due to circumstances far beyond our control, such as lack of standardization, cost considerations and pending Federal proposals. For E-pedigree to be a success, the implementation deadline must be extended at least 24 months." In fact, all sectors of the pharmaceutical community--manufacturers, wholesalers and retailers agree that logistical challenges require more time to be successfully overcome.

Wilcox advocated the following four steps to ensure pharmacists are able to effectively implement E-pedigree:

-- Adjust the implementation date to January 1, 2011, with additional time for the adoption of interoperable standards and technology to reach the retail level.

-- Adopt a phased-in approach to implementation.

-- Grandfather pre-implementation drugs for one year.

-- Only adopt inference if liability does not attach to the drug container recipient.

Another compelling reason for the delay is the financial considerations that must be taken into account. Wilcox said, "Without a uniform technology standard, pharmacists will be forced to purchase and maintain multiple track and trace technologies--readers, scanners, software and the like. The cost of E-pedigree regulation is substantial for community pharmacy and must be compensated. The costs to a retail pharmacy have been estimated at anywhere from $10,000 to $40,000 per location. Chain pharmacies have stated that once the plans of upstream trading partners are known, it will take an additional 15 -18 months to implement E-pedigree. For the small businesses in the independent pharmacy sector lacking the resources of larger chains, the consequences will be even worse." The state has created an unfunded mandate by failing to have any mechanisms to help offset the cost to pharmacies.

In California, NCPA represents 2,215 community pharmacies with over 30,000 employees--a substantial portion of the California retail pharmacy marketplace. The proposed changes will enable the transition to E-pedigree to be efficient and effective, ultimately benefitting public safety.

View the entire Wilcox testimony at the following link: http://www.ncpanet.org/pdf/leg/testimony-pedigreewilcox20071204.pdf

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. For more information, go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Meth Project Chairman Testifies Before U.S. Senate Finance Committee
2. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
3. AIDS Action Committee Testifies to Protect the Privacy of People Seeking Healthcare in Massachusetts
4. URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management
5. Biomoda President Testifies Before New Mexico Legislature Supporting Clinical Funding for Early Lung Cancer
6. Greenway Medical Technologies Executive Testifies Before Congress
7. Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors Access to Care, American Association for Homecare Testifies
8. MRI finds breast cancer before it becomes dangerous
9. Removing Ovaries Before Menopause Leads to Memory, Movement Troubles
10. Underage drinking starts before adolescence
11. Fat Builds Up in Hearts Before Diabetes Onset
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: